SNDX
Syndax Pharmaceuticals Inc
18.20$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +0.0% | +0.0% | +0.0% | +291.1% | -68.2% | +0.0% | +0.0% | +0.3% | -0.3% | +0.0% | +0.0% | +0.3% | -0.3% | +0.0% | +0.0% | +0.3% | -0.3% | +0.0% | +3,165.2% | +922.8% | -100.0% | – | – | – | – | – | – | – | -100.0% | – | +257.1% | -38.6% | +161.0% | +89.4% | +20.8% | +49.3% | -5.3% | +12.2% | – | |
| – | -25.7% | +16.8% | +4.9% | +11.3% | +31.3% | -2.7% | -4.0% | -5.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | -9.1% | -1.8% | +6.5% | -1.7% | +34.5% | -98.0% | +8,833.3% | -98.9% | +1,477,800.0% | -100.0% | +41,200.0% | +7.1% | +44.5% | +64.2% | -174.9% | – | +21.8% | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +291.1% | -68.2% | +0.0% | +0.0% | +0.3% | -0.3% | +0.0% | +0.0% | +0.3% | -0.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +3,165.2% | +921.9% | -100.1% | – | – | – | – | – | – | – | -101.1% | – | +257.1% | -38.6% | +149.4% | +91.5% | +19.3% | +60.0% | -11.2% | +11.8% | – | |
| – | -31.0% | +12.7% | +3.2% | +23.6% | +36.2% | -7.6% | -3.2% | -5.1% | +12.2% | -28.7% | +9.0% | -19.3% | -4.2% | +0.6% | +14.4% | +31.7% | +7.7% | +40.9% | -22.9% | +51.8% | -6.7% | +25.6% | -1.0% | -9.5% | +18.4% | +7.0% | +2.1% | +12.4% | +41.0% | +2.5% | -13.9% | +45.9% | -7.7% | -5.9% | +1.0% | -9.6% | +39.7% | -25.2% | +15.6% | – | |
| – | -9.1% | +32.2% | +9.0% | -16.8% | +14.6% | +17.3% | -6.5% | -7.9% | -5.6% | +0.5% | -11.5% | +4.1% | +41.0% | +16.4% | +2.2% | -3.7% | -19.0% | +20.2% | +3.0% | +16.4% | +1.9% | -1.3% | +16.9% | +3.1% | +23.7% | +17.4% | +24.7% | +15.8% | +155.6% | -47.8% | +26.2% | +7.0% | +21.2% | +8.9% | +6.8% | +2.5% | +11.2% | -24.7% | +10.5% | – | |
| – | -26.4% | +17.8% | +4.9% | +11.3% | +31.3% | -2.7% | -4.0% | -5.7% | +8.2% | -22.9% | +3.7% | -14.1% | +7.8% | +6.1% | +9.8% | +19.1% | +0.0% | +36.1% | -17.5% | +42.7% | -4.9% | +19.6% | +2.3% | -6.8% | +19.6% | +9.5% | +8.0% | +13.4% | +38.2% | +2.1% | -2.3% | +31.3% | +1.9% | -1.1% | +3.0% | -4.6% | +31.0% | -27.3% | +13.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -138.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +256.7% | -72.9% | +12.0% | +41.7% | +245.7% | -66.6% | -3.4% | +6.3% | +298.0% | -76.7% | +10.8% | -21.2% | +297.7% | -71.4% | +42.1% | -0.5% | +0.0% | -1.9% | +1.8% | +2.4% | -98.9% | +9,200.0% | +6.8% | +151.5% | -97.5% | -7.0% | -12.5% | +100.0% | -10.0% | -12.7% | -18.2% | -48.9% | +20,795.7% | +67.5% | -2.4% | +5.4% | +536.3% | -77.5% | +7.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -138.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -246.4% | – | – | – | – | -363.1% | – | – | – | – | -253.9% | – | – | – | +39.6% | -103.8% | – | – | +3.2% | +4.1% | -101.6% | – | +113.5% | -60.5% | -1,201.1% | – | – | – | – | -100.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -138.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -137.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.